Publication | Open Access

Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)

UrologySurgical OncologyOptimal CandidateGenitourinary CancerMedicineRiskOutcomes ResearchMulti-institutional RegistryNovel Risk ScoreSurgeryOncologyKidney Research